SIGN UPLog In

General

Financials

People

Founders
Employee Profiles

Activity

Recent News
Arvinas
Arvinas

Company

Investment-firm

Last deal

$350M

Amount

Post-IPO Equity

Stage

27.11.2023

Date

3

all rounds

$461.6M

Total amount

Financing round

General

About Company
Arvinas is a pharmaceutical company that develops novel therapeutics to treat a variety of diseases.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Arvinas Holding Co., LLC

founded date

01.01.2013

founders

Number of employees

101-250

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Using its proprietary Proteolysis-Targeting Chimera (PROTAC) platform, Arvinas engineers PROTAC targeted protein degraders that selectively and efficiently degrade and remove disease-causing proteins. The company has two clinical-stage programs, ARV-110 for the treatment of metastatic castrate-resistant prostate cancer, and ARV-471 for the treatment of locally advanced or metastatic ER+/HER2- breast cancer, in addition to a robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets.
Contacts

location

New Haven, CT, USA

Contact Email

Phone number

Website URL

http://www.arvinas.com

Social url

Similar Companies
1000
Covagen
CovagenCovagen is a biopharmaceutical company that develops protein-based therapeutics for the treatment of inflammatory diseases and cancer..
Covagen

Covagen

Covagen is a biopharmaceutical company that develops protein-based therapeutics for the treatment of inflammatory diseases and cancer..

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

8952 Schlieren, Switzerland

total rounds

4

total raised

$106.63M
IFM Therapeutics
IFM TherapeuticsIFM Therapeutics develops medicines that target the innate immune system to treat inflammatory and autoimmune disorders.
IFM Therapeutics

IFM Therapeutics

IFM Therapeutics develops medicines that target the innate immune system to treat inflammatory and autoimmune disorders.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Cambridge, MA, USA

total rounds

2

total raised

$82.5M
Macrophage Pharma
Macrophage PharmaMacrophage Pharma develops therapies to boost the immune system against cancer.
Macrophage Pharma

Macrophage Pharma

Macrophage Pharma develops therapies to boost the immune system against cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

Dublin, OH, USA

total rounds

1

total raised

$10.95M
AltruBio
AltruBioAltruBio is a biopharmaceutical company developing targeted antibody therapeutics for cancer and immune-related inflammatory diseases.
AltruBio

AltruBio

AltruBio is a biopharmaceutical company developing targeted antibody therapeutics for cancer and immune-related inflammatory diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Los Altos, CA, USA

total rounds

5

total raised

$327.61M

Financials

Funding Rounds
4
3

Number of Funding Rounds

$461.6M

Money Raised

Their latest funding was raised on 27.11.2023. Their latest investor Boxer Capital. Their latest round Post-IPO Equity

Date 
Funding Round 
Investors 
Money Raised 
Lead 
27.11.2023
Post-IPO Equity
10
$350M
RTW Investments LLC
RTW Investments LLC
04.04.2018
Series C
9
$55M
Nextech Invest
Nextech Invest
21.10.2015
Series B
5
$41.6M
Canaan Partners
Canaan Partners
5AM Ventures
5AM Ventures
RA Capital Management
RA Capital Management
RTW Investments LLC

RTW Investments LLC

RTW Investments is an innovative health care investment firm.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Financial Services, Health Care

Location

New York, NY, USA

count Of Investments

88

count Of Exists

3
Nextech Invest

Nextech Invest

Nextech Invest is a venture capital and private equity firm that focuses on precision therapies in oncology.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital, Biotechnology

Location

Zürich, Switzerland

count Of Investments

76

count Of Exists

8
Canaan Partners

Canaan Partners

Canaan Partners is an early stage venture capital firm.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Menlo Park, CA, USA

count Of Investments

622

count Of Exists

138
5AM Ventures

5AM Ventures

5AM Ventures is a venture capital firm that invests in early-stage companies in the life sciences industry.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Biotechnology, Financial Services

Location

Menlo Park, CA, USA

count Of Investments

154

count Of Exists

19
RA Capital Management

RA Capital Management

RA Capital Management is a Boston-based investment advisor that specializes in the life-sciences and drug development sectors.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Health Care, Financial Services

Location

Boston, MA, USA

count Of Investments

377

count Of Exists

33
Investments
1
Date 
name 
Lead 
type 
Raised 
27.02.2020
Oerth Bio
Oerth Bio
No
Corporate Round
$55M
Oerth Bio

Oerth Bio

Oerth Bio is an agriculture-focused biotech firm revolutionizing farming for the future.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Farming, Biotechnology, AgTech

Location

New Haven, CT, USA

total rounds

1

total raised

$55M
Co-Investors
Investors
18
1

Number of lead investors

18

Number of investors

Investor 
Lead 
Round 
Partners 
Boxer Capital
Boxer Capital
No
Post-IPO Equity
—
Citadel Global Equities
Citadel Global Equities
No
Post-IPO Equity
—
Avidity Partners
Avidity Partners
No
Post-IPO Equity
—
Boxer Capital

Boxer Capital

Boxer Capital supports biotech public companies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology

Location

Windermere, FL 34786, USA

count Of Investments

90

count Of Exists

7
Citadel Global Equities

Citadel Global Equities

Citadel Global Equities (CGE) is a new division focused on basic equities for the company.

Sector

General Industrials

Subsector

Diversified Industrials

count Of Investments

1
Avidity Partners

Avidity Partners

Avidity Partners is an investment management firm that offers financial services.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Finance

count Of Investments

51

count Of Exists

1

People

Founders
2

Lewis B. Cullman

current job

Arvinas
Arvinas

organization founded

1
Lewis B. Cullman

Lewis B. Cullman

Craig M. Crews
Craig M. Crews

Craig M. Crews

Craig Crews is the founder of Arvinas.

current job

Halda Therapeutics
Halda Therapeutics

organization founded

2
Craig M. Crews

Craig M. Crews

Employee Profiles
27
Justin Scheidegger

Justin Scheidegger

Director, it operations, infrastructure and security

Director, it operations, infrastructure and security

Jessica Teh

Jessica Teh

Senior research scientist

Senior research scientist

Rituraj Pal

Rituraj Pal

Senior research scientist, project lead

Senior research scientist, project lead

Marcia Dougan Moore
Marcia Dougan Moore

Marcia Dougan Moore

Senior Vice President, Strategic Operations

Senior Vice President, Strategic Operations

Kerline Poulard

Kerline Poulard

Senior accountant

Senior accountant

Debby Nickischer

Debby Nickischer

Research scientist

Research scientist

Ron Peck
Ron Peck

Ron Peck

CMO

CMO

Elizabeth Sachatello

Elizabeth Sachatello

Director, human resources

Director, human resources

Activity

Recent News
17
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

week